News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
514,402 Results
Type
Article (37615)
Company Profile (156)
Press Release (476631)
Multimedia
Podcasts (77)
Webinars (12)
Section
Business (151057)
Career Advice (1548)
Deals (29067)
Drug Delivery (107)
Drug Development (70371)
Employer Resources (128)
FDA (11931)
Job Trends (11413)
News (269663)
Policy (29613)
Tag
Academia (1974)
Accelerated approval (5)
Adcomms (24)
Allergies (78)
Alliances (46787)
ALS (82)
Alzheimer's disease (1256)
Antibody-drug conjugate (ADC) (138)
Approvals (11899)
Artificial intelligence (233)
Autoimmune disease (22)
Automation (11)
Bankruptcy (277)
Best Places to Work (8893)
BIOSECURE Act (19)
Biosimilars (101)
Biotechnology (80)
Bladder cancer (67)
Brain cancer (34)
Breast cancer (275)
Cancer (2183)
Cardiovascular disease (166)
Career advice (1307)
Career pathing (23)
CAR-T (136)
CDC (31)
Cell therapy (362)
Cervical cancer (17)
Clinical research (57635)
Collaboration (879)
Company closure (2)
Compensation (554)
Complete response letters (25)
COVID-19 (2572)
CRISPR (51)
C-suite (232)
Cystic fibrosis (75)
Data (2184)
Decentralized trials (1)
Denatured (20)
Depression (47)
Diabetes (263)
Diagnostics (4121)
Digital health (13)
Diversity (4)
Diversity, equity & inclusion (36)
Drug discovery (110)
Drug pricing (128)
Drug shortages (33)
Duchenne muscular dystrophy (104)
Earnings (56275)
Editorial (44)
Employer branding (17)
Employer resources (115)
Events (69871)
Executive appointments (608)
FDA (13112)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (6)
Funding (644)
Gene editing (104)
Generative AI (16)
Gene therapy (318)
GLP-1 (785)
Government (4378)
Grass and pollen (5)
Guidances (148)
Healthcare (12660)
Huntington's disease (24)
IgA nephropathy (34)
Immunology and inflammation (114)
Immuno-oncology (4)
Indications (33)
Infectious disease (2731)
Inflammatory bowel disease (114)
Inflation Reduction Act (9)
Influenza (59)
Intellectual property (96)
Interviews (268)
IPO (12548)
IRA (46)
Job creations (2916)
Job search strategy (1127)
Kidney cancer (8)
Labor market (33)
Layoffs (389)
Leadership (14)
Legal (7868)
Liver cancer (60)
Lung cancer (317)
Lymphoma (157)
Machine learning (9)
Management (40)
Manufacturing (326)
MASH (74)
Medical device (6602)
Medtech (6605)
Mergers & acquisitions (17096)
Metabolic disorders (726)
Multiple sclerosis (76)
NASH (21)
Neurodegenerative disease (100)
Neuropsychiatric disorders (28)
Neuroscience (1801)
NextGen: Class of 2025 (4312)
Non-profit (2999)
Now hiring (15)
Obesity (398)
Opinion (233)
Ovarian cancer (68)
Pain (85)
Pancreatic cancer (88)
Parkinson's disease (148)
Partnered (14)
Patents (239)
Patient recruitment (87)
Peanut (40)
People (41511)
Pharmaceutical (73)
Pharmacy benefit managers (19)
Phase I (17280)
Phase II (25160)
Phase III (19909)
Pipeline (1323)
Policy (187)
Postmarket research (2234)
Preclinical (7263)
Press Release (43)
Prostate cancer (111)
Psychedelics (31)
Radiopharmaceuticals (244)
Rare diseases (362)
Real estate (4134)
Recruiting (54)
Regulatory (19510)
Reports (24)
Research institute (1823)
Resumes & cover letters (227)
Rett syndrome (8)
RNA editing (6)
RSV (51)
Schizophrenia (84)
Series A (109)
Series B (61)
Service/supplier (6)
Sickle cell disease (47)
Special edition (11)
Spinal muscular atrophy (148)
Sponsored (25)
Startups (2682)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (58)
The Weekly (55)
Vaccines (794)
Venture capitalists (36)
Weight loss (280)
Women's health (20)
Worklife (11)
Date
Today (30)
Last 7 days (395)
Last 30 days (1809)
Last 365 days (24291)
2025 (11574)
2024 (26815)
2023 (30183)
2022 (39661)
2021 (42527)
2020 (40524)
2019 (33688)
2018 (25751)
2017 (25409)
2016 (24252)
2015 (28030)
2014 (22171)
2013 (18378)
2012 (19576)
2011 (20387)
2010 (18699)
Location
Africa (695)
Alabama (43)
Alaska (3)
Arizona (128)
Arkansas (7)
Asia (34263)
Australia (5490)
California (5072)
Canada (1770)
China (543)
Colorado (215)
Connecticut (212)
Delaware (144)
Europe (75767)
Florida (827)
Georgia (157)
Hawaii (1)
Idaho (33)
Illinois (442)
India (27)
Indiana (264)
Iowa (11)
Japan (182)
Kansas (81)
Kentucky (19)
Louisiana (13)
Maine (29)
Maryland (807)
Massachusetts (3835)
Michigan (133)
Minnesota (214)
Mississippi (2)
Missouri (58)
Montana (23)
Nebraska (12)
Nevada (51)
New Hampshire (28)
New Jersey (1572)
New Mexico (19)
New York (1520)
North Carolina (772)
North Dakota (6)
Northern California (2271)
Ohio (155)
Oklahoma (7)
Oregon (23)
Pennsylvania (1079)
Puerto Rico (12)
Rhode Island (21)
South America (1000)
South Carolina (18)
South Dakota (1)
Southern California (1898)
Tennessee (69)
Texas (665)
United States (18947)
Utah (119)
Virginia (151)
Washington D.C. (55)
Washington State (408)
West Virginia (3)
Wisconsin (43)
514,402 Results for "cns pharmaceuticals ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CNS Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 16, 2025
·
6 min read
Press Releases
Coave Therapeutics Launches coAAV-CSF-01, a Novel CNS-Targeted Gene Therapy Vector for Neurodegenerative and other CNS Diseases
May 12, 2025
·
4 min read
Press Releases
CNS Pharmaceuticals’ Chief Medical Officer, Sandra Silberman, MD, PhD to Present at the 2025 Brain Tumor Biotech Summit
June 5, 2025
·
4 min read
Press Releases
CNS Pharmaceuticals Acquires Orphan Drug Designation for Novel, Late Stage Abeotaxane, TPI 287
May 14, 2025
·
5 min read
Press Releases
CNS Pharmaceuticals Reports Full Year 2024 Financial Results
April 1, 2025
·
8 min read
Press Releases
Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders
April 7, 2025
·
10 min read
Press Releases
CNS Pharmaceuticals Announces Reverse Stock Split
February 19, 2025
·
4 min read
Press Releases
CNS Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
May 13, 2025
·
4 min read
Press Releases
CNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme
March 26, 2025
·
8 min read
Press Releases
CNS Pharmaceuticals to Present at the BIO CEO & Investor Conference
February 10, 2025
·
2 min read
1 of 51,441
Next
